Off-Label Treatment Pearls with Dr. Ted Rosen
Next Steps in Derm and the Journal of Drugs in Dermatology, in partnership with the Dermatology Education Foundation (DEF) and Physicians Resources, interviewed Dr. Ted Rosen (Professor, Vice-Chair of Dermatology, and Chief of Dermatology at the Houston Veterans Affairs Medical Center) on his favorite off-label treatment pearls. Watch as he shares how to use indomethacin for the angry red scrot …
Next Steps in Derm and the Journal of Drugs in Dermatology, in partnership with the Dermatology Education Foundation (DEF) and Physicians Resources, interviewed Dr. Ted Rosen (Professor, Vice-Chair of Dermatology, and Chief of Dermatology at the Houston Veterans Affairs Medical Center) on his favorite off-label treatment pearls. Watch as he shares how to use indomethacin for the angry red scrot … Continue reading "Off-Label Treatment Pearls with Dr. Ted Rosen"
Retinoids are a mainstay of dermatologic therapy. When properly formulated, retinoids available over the counter offer consumers an easily accessible, reasonably priced option. Retinol has been shown to improve fine lines and wrinkles, hyperpigmentation, skin roughness, and the appearance of photoaged skin in short term studies. This study looks at the efficacy and safety of continued use of a s … 
The November issue of the Journal of Drugs in Dermatology (JDD) focuses on lasers, lights sources, and devices featuring original articles and case reports exploring topics such as combination of platelet rich plasma and 1550 nm fractional laser for androgenetic alopecia, safety of combination laser procedures in single clinic visit, efficacy of a fractionated 1540 nm erbium glass laser in the tre … 
In case you missed it, the 17th Annual Women’s & Pediatric Dermatology Symposium offered dermatologists a practical approach to treat and evaluate the “aging face.” Dr. Jacqueline Watchmaker, a dermatologist from Scottsdale, Arizona, and cosmetic dermatology extraordinaire, discussed her approach to helping patients feel and look their best. Read on for a full summary of this session!
… 
Androgenic alopecia (AGA) is one of the most common forms of hair loss and represents a frequently faced disabling concern in dermatology visits. Targeting the 5α-dihydrotestosterone (DHT) pathway has been shown to be an efficacious mechanism of action, with finasteride being the only systemic FDA-approved drug to treat male AGA. Recently, its sister drug, dutasteride, has been increasingly utili …